On the Article “Drugs Targeting Protease-Activated Receptor-4 Improve the Anti-Thrombotic Therapeutic Window”

Annals of Translational Medicine - China
doi 10.21037/atm.2017.11.31
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

AME Publishing Company

Related search

Therapeutic Drugs Targeting 2019-nCoV Main Protease by High-Throughput Screening

2020English

The Decreased Expression of Protease-Activated Receptor 4 in Esophageal Squamous Carcinoma

Neoplasma
Cancer Research
2014English

Protease-Activated Receptor 2 (PAR2)

Science-Business eXchange
2012English

Erratum To: Protease-Activated-Receptor-2 Affects Protease-Activated-Receptor-1-Driven Breast Cancer

Cellular and Molecular Life Sciences
Molecular NeuroscienceMolecular MedicineCell BiologyMolecular BiologyPharmacologyCellular
2016English

Protease-Activated Receptor 1 (PAR1)

Science-Business eXchange
2012English

Protease-Activated Receptor-4: A Novel Mechanism of Inflammatory Pain Modulation

British Journal of Pharmacology
Pharmacology
2007English

Targeting Liver Fibrosis With a Cell-Penetrating Protease-Activated Receptor-2 (PAR2) Pepducin

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2016English

Protease-Activated Receptor 4 Deficiency Offers Cardioprotection After Acute Ischemia Reperfusion Injury

Journal of Molecular and Cellular Cardiology
Cardiovascular MedicineMolecular BiologyCardiology
2016English

Evolution of the Protease-Activated Receptor Family in Vertebrates

International Journal of Molecular Medicine
MedicineGenetics
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy